283 results on '"Medof, M. Edward"'
Search Results
2. DAF in diabetic patients is subject to glycation/inactivation at its active site residues
3. Critical Role of CD55 in Controlling Wound Healing
4. KLF4 and CD55 expression and function depend on each other
5. CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity
6. C5aR1 regulates migration of suppressive myeloid cells required for costimulatory blockade-induced murine allograft survival
7. KLF4 and CD55 expression and function depend on each other.
8. Disabled C3ar1/C5ar1 Signaling in Foxp3+ T Regulatory Cells Leads to TSDR Demethylation and Long-Term Stability
9. Solution Structure of a Functionally Active Fragment of Decay-Accelerating Factor
10. Structure of Decay-Accelerating Factor Bound to Echovirus 7: A Virus-Receptor Complex
11. Mammalian Glycophosphatidylinositol Anchor Transfer to Proteins and Posttransfer Deacylation
12. The Affected Gene Underlying the Class K Glycosylphosphatidylinositol (GPI) Surface Protein Defect Codes for the GPI Transamidase
13. Resistance to Apoptosis Caused by PIG-A Gene Mutations in Paroxysmal Nocturanal Hemoglobinuria
14. COOH-Terminal Processing of Nascent Polypeptides by the Glycosylphosphatidylinositol Transamidase in the Presence of Hydrazine is Governed by the Same Parameters as Glycosylphosphatidylinositol Addition
15. A Defect in Glycosylphosphatidylinositol (GPI) Transamidase Activity in Mutant K Cells is Responsible for their Inability to Display GPI Surface Proteins
16. Complement Regulates CD4 T-Cell Help to CD8 T Cells Required for Murine Allograft Rejection
17. Amelioration of Lytic Abnormalities of Paroxysmal Nocturnal Hemoglobinuria with Decay-Accelerating Factor
18. Stimulation of Glycogen Synthesis by Insulin in Human Erythroleukemia Cells Requires the Synthesis of Glycosyl-Phosphatidylinositol
19. Heightened Complement Sensitivity of Acquired Immunodeficiency Syndrome Lymphocytes Related to Diminished Expression of Decay-Accelerating Factor
20. Characterization of the Decay-Accelerating Factor Gene Promoter Region
21. In vitro Attachment of Glycosyl-Inositolphospholipid Anchor Structures to Mouse Thy-1 Antigen and Human Decay-Accelerating Factor
22. Cloning and Characterization of cDNAs Encoding the Complete Sequence of Decay-Accelerating Factor of Human Complement
23. Normal Polymorphic Variations and Transcription of the Decay Accelerating Factor Gene in Paroxysmal Nocturnal Hemoglobinuria Cells
24. Glycolipid Reanchoring of T-Lymphocyte Surface Antigen CD8 Using the 3′ End Sequence of Decay-Accelerating Factor's mRNA
25. Synthesis of Mannosylglucosaminylinositol Phospholipids in Normal but Not Paroxysmal Nocturnal Hemoglobinuria Cells
26. Release of Soluble Immune Complexes from Immune Adherence Receptors on Human Erythrocytes is Mediated by C3b Inactivator Independently of β 1H and is Accompanied by Generation of C3c
27. Antigen-presenting cell-derived complement modulates graft-versus-host disease
28. Graft-derived complement as a mediator of transplant injury
29. Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia
30. Response to Comment on: Lin et al. (2010) Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin. Diabetes;59: 2247–2252
31. Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin
32. RTK signaling requires C3ar1/C5ar1 and IL‐6R joint signaling to repress dominant PTEN, SOCS1/3 and PHLPP restraint
33. Identification of a PIG-A related processed gene on chromosome 12
34. Synthesis of the GPI Anchor
35. A defect in glycosylphosphatidylinositol (GPI) transamidase activity in mutant K cells is responsible for their inability to display GPI surface proteins
36. Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection
37. Resonance assignments of the central complement control protein module pair of human decay accelerating factor
38. Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritis
39. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies
40. Impaired growth and elevated Fas receptor expression in PIGA+ stem cells in primary paroxysmal nocturnal hemoglobinuria
41. Follicular B2 Cell Activation and Class Switch Recombination Depend on Autocrine C3ar1/C5ar1 Signaling in B2 Cells
42. VEGFR2 survival and mitotic signaling depends on joint-activation of associated C3ar1/C5ar1 and IL-6R-gp130
43. Decay-Accelerating Factor Confers Protection Against Complement-Mediated Podocyte Injury in Acute Nephrotoxic Nephritis
44. Activation of the Alternative Complement Pathway by Exposure of Phosphatidylethanolamine and Phosphatidylserine on Erythrocytes from Sickle Cell Disease Patients
45. Toll like receptor-induced murine dendritic cell activation requires dendritic cell-intrinsic complement
46. RTK signaling requires C3ar1/C5ar1 and IL‐6R joint signaling to repress dominant PTEN, SOCS1/3 and PHLPP restraint.
47. Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome
48. T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival
49. DAF in diabetic patients is subject to glycation/inactivation at its active site residues
50. Letter to the Editor: Resonance assignments of the central complement control protein module pair of human decay accelerating factor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.